Neurometrix Inc
(NURO)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2022 | 03-2022 | 12-2021 | 09-2021 | 06-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -2,119 | -959 | -2,282 | -1,279 | -591 |
| Depreciation Amortization | -11 | 13 | 76 | 104 | 80 |
| Accounts receivable | -237 | -373 | 24 | -306 | -123 |
| Accounts payable and accrued liabilities | 117 | 77 | 142 | 175 | 147 |
| Other Working Capital | 371 | 161 | -1,233 | -1,098 | -572 |
| Other Operating Activity | 300 | 340 | 1,199 | 843 | 491 |
| Operating Cash Flow | $-1,579 | $-740 | $-2,074 | $-1,561 | $-569 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -13 | -5 | -132 | -125 | -83 |
| Purchase Of Investment | -16,929 | N/A | N/A | N/A | N/A |
| Investing Cash Flow | $-16,942 | $-5 | $-132 | $-125 | $-83 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 1,951 | 1,943 | 19,551 | 19,674 | 3,790 |
| Financing Cash Flow | $1,951 | $1,943 | $19,551 | $19,674 | $3,790 |
| Beginning Cash Position | 22,572 | 22,572 | 5,226 | 5,226 | 5,226 |
| End Cash Position | 6,002 | 23,769 | 22,572 | 23,214 | 8,364 |
| Net Cash Flow | $-16,570 | $1,197 | $17,346 | $17,987 | $3,138 |
| Free Cash Flow | |||||
| Operating Cash Flow | -1,579 | -740 | -2,074 | -1,561 | -569 |
| Capital Expenditure | -13 | -5 | -132 | -125 | -83 |
| Free Cash Flow | -1,592 | -746 | -2,205 | -1,686 | -652 |